Search research articles
Contact Us
Filters
Showing results (21-30 of 252) with videos related to
Page
of 26
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1989
Metabolic implications of chiral centres in psychotropic drugs
R T Coutts, G B Baker
Cellular and Molecular Neurobiology
|
May 13, 1999
Chirality and drugs used in psychiatry: nice to know or need to know?
R M Lane, G B Baker
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1989
Metabolism of monoamine oxidase inhibitors
G B Baker, R T Coutts
Drug Metabolism Letters
|
April 10, 2009
Involvement of cytochromes P450 2D6, 2B6 and 2C19 in the metabolism of (-)-deprenyl and N-methyl,N-propargylphenylethylamine
K A Rittenbach, G B Baker
The International Journal of Neuroscience
|
September 1, 1988
Neuropsychological correlates of urinary amine metabolites in Tourette's syndrome
R A Bornstein, G B Baker
Progress in Neuro-Psychopharmacology
|
January 1, 1981
Interactions of trace amines with dopamine in rat striatum
G B Baker, D L Yasensky
Journal of Neurochemistry
|
June 1, 1994
5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination
D B Goodnough, G B Baker
Journal of Neural Transmission. Supplementum
|
January 1, 1994
Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex
D B Goodnough, G B Baker
Epilepsia
|
May 1, 1994
Anticonvulsant activities of 4-bromobenzaldehyde semicarbazone
J R Dimmock, G B Baker
Canadian Journal of Biochemistry
|
April 1, 1974
The subcellular distribution of some monoamines following their intraventricular injection into the rat
A A Boulton, G B Baker
Page
of 26
Search research articles
Search
Showing results (21-30 of 252) with videos related to
Sort By:
Page
of 26
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1989
Metabolic implications of chiral centres in psychotropic drugs
R T Coutts, G B Baker
Cellular and Molecular Neurobiology
|
May 13, 1999
Chirality and drugs used in psychiatry: nice to know or need to know?
R M Lane, G B Baker
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1989
Metabolism of monoamine oxidase inhibitors
G B Baker, R T Coutts
Drug Metabolism Letters
|
April 10, 2009
Involvement of cytochromes P450 2D6, 2B6 and 2C19 in the metabolism of (-)-deprenyl and N-methyl,N-propargylphenylethylamine
K A Rittenbach, G B Baker
The International Journal of Neuroscience
|
September 1, 1988
Neuropsychological correlates of urinary amine metabolites in Tourette's syndrome
R A Bornstein, G B Baker
Progress in Neuro-Psychopharmacology
|
January 1, 1981
Interactions of trace amines with dopamine in rat striatum
G B Baker, D L Yasensky
Journal of Neurochemistry
|
June 1, 1994
5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination
D B Goodnough, G B Baker
Journal of Neural Transmission. Supplementum
|
January 1, 1994
Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex
D B Goodnough, G B Baker
Epilepsia
|
May 1, 1994
Anticonvulsant activities of 4-bromobenzaldehyde semicarbazone
J R Dimmock, G B Baker
Canadian Journal of Biochemistry
|
April 1, 1974
The subcellular distribution of some monoamines following their intraventricular injection into the rat
A A Boulton, G B Baker
Page
of 26